-+ 0.00%
-+ 0.00%
-+ 0.00%

COGENT BIOSCIENCES SHARES RISE 7.2% PREMARKET AFTER FDA ACCEPTS APPLICATION TO REVIEW RARE DISEASE DRUG

Reuters·03/16/2026 12:19:35

Please log in to view news